Canada's Spectral hoping to win US approval for sepsis treatment

July 13 (Reuters) - A small Canadian drugmaker is in the

final stages of testing technology designed to treat sepsis, the

surprisingly common condition that killed boxing legend Muhammad

Ali.

Read more